HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 322 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $344,188 | +22.5% | 6,049 | -13.3% | 0.00% | 0.0% |
| Q4 2021 | $281,000 | -28.5% | 6,977 | -27.8% | 0.00% | 0.0% |
| Q3 2021 | $393,000 | -6.0% | 9,664 | +4.9% | 0.00% | 0.0% |
| Q2 2021 | $418,000 | -12.9% | 9,212 | -20.0% | 0.00% | 0.0% |
| Q1 2021 | $480,000 | +17.9% | 11,512 | +20.8% | 0.00% | 0.0% |
| Q4 2020 | $407,000 | – | 9,526 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 14,092,771 | $206,177,000 | 28.12% |
| BB BIOTECH AG | 8,322,860 | $121,763,000 | 3.90% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 398,633 | $4,579,000 | 2.84% |
| DOHENY ASSET MANAGEMENT /CA | 227,193 | $3,324,000 | 2.43% |
| SNYDER CAPITAL MANAGEMENT L P | 2,833,759 | $41,458,000 | 2.24% |
| First Light Asset Management, LLC | 938,399 | $13,729,000 | 2.19% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,027,164 | $132,067,000 | 1.77% |
| Taylor Wealth Management Partners | 204,277 | $2,989,000 | 1.72% |
| Sterling Global Strategies LLC | 22,000 | $321,860,000 | 1.63% |
| Granite Investment Partners, LLC | 988,939 | $14,468,000 | 1.06% |